A 2019 laboratory-based UK study demonstrated that Enterosgel can adsorb (bind) bacterial toxins and bile acids which could help treat tummy bugs and IBS.
The study tested the adsorption of bacterial toxins released from Clostridium difficile, Shigella and E.coli, which can cause inflammation and damage to the mucosal cells lining the colon resulting in diarrhoea.
The results showed that Enterosgel has substantial adsorption or binding capacity for these bacterial toxins and to a lesser extent the most common bile acids.
Also, the study supports previous investigations which have shown that Enterosgel can adsorb harmful substances and common viruses which can cause gastrointestinal disorders and diarrhoea.